Advantages – performance measure [Two-Stage / GS Designs]

posted by d_labes  – Berlin, Germany, 2015-06-05 13:21 (3542 d 21:57 ago) – Posting: # 14917
Views: 19,402

Dear ElMaestro!

❝ We really need some kind of summary statistic that is the ultimate indicator of whether one method is better than the other. ...


Really good point!

Have a look into
Kieser, Rauch
"Two-stage designs for cross-over bioequivalence trials"
Stat Med 2015
DOI: 10.1002/sim.6487

They cite and use a performance score according to
Liu et al.
"Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval"
Stat Med 2008; 27:584–596.

But don't ask me for details! I haven't had a look into the last reference up to now :lookaround:.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
92 visitors (0 registered, 92 guests [including 9 identified bots]).
Forum time: 10:19 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5